Get started
Author

Micaela Harrasser

Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin
2016 · Jonathan H. Foley, Bethany L. Walton, et al. · EBioMedicine · 152
Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation
2020 · Simon T. Abrams, Dunhao Su, et al. · Blood · 73
PDF
An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors
2017 · Satyen Harish Gohil, Solange Rosa Paredes-Moscosso, et al. · OncoImmunology · 58
Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review)
2014 · SADEK MALAS, MICAELA HARRASSER, et al. · Oncology Reports · 50
PDF
Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC
2022 · Micaela Harrasser, Satyen Harish Gohil, et al. · Breast Cancer Research · 41
PDF
Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
2021 · R.S.A. Goedegebuure, M. Harrasser, et al. · OncoImmunology · 36
PDF
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations
2024 · Tessa S. Groen-van Schooten, Micaela Harrasser, et al. · Frontiers in Immunology · 17
Ibrutinib enhances the efficacy of ROR1 bispecific T cell engager mediated cytotoxicity in chronic lymphocytic leukaemia
2019 · Satyen H. Gohil, Rachel Evans, et al. · British Journal of Haematology · 16
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition
2023 · Tom van den Ende, Aiarpi Ezdoglian, et al. · OncoImmunology · 10
PDF
Preclinical development of novel humanised ROR1 targeting chimeric antigen receptor T cells and bispecific T-cell engagers
2017 · Satyen Gohil, Solange Paredes-Moscosso, et al. · The Lancet · 8
Novel Humanised ROR1 Chimeric Antigen Receptors for the Treatment of Haematological Malignancies
2016 · Satyen Harish Gohil, Marco Della Peruta, et al. · Blood · 3
Abstract 2324: Characterizing the secretome of freshly dissociated gastroesophageal tumor biopsies to identify immune suppressive factors
2023 · Jasper Sanders, Micaela H. Harrasser, et al. · Cancer Research
A next generation inducible armored CAR to overcome the immunosuppressive tumor microenvironment and enhances cytotoxicity of CAR-T and TILs.
2022 · David Granger, Micaela Harrasser, et al. · Journal of Clinical Oncology
ROR1-targeted adoptive immunotherapies
2020 · Micaela Harrasser · UCL Discovery (University College London)
A ROR1 Bispecific T Cell Engager for the Treatment of Chronic Lymphocytic Leukaemia Demonstrates Enhanced Function Following Ibrutinib Treatment
2017 · Satyen H. Gohil, Solange Rosa Paredes-Moscosso, et al. · Blood
Novel ROR1 Antibody Is Able to Trigger Specific and Superior Complement-Dependent Cytotoxicity (CDC) on Primary CLL Cells
2016 · Solange R Paredes-Moscosso, Marco Della Peruta, et al. · Blood
A Novel Humanised ROR1 Bi-Specific T-Cell Engager Molecule for the Treatment of Chronic Lymphocytic Leukaemia
2016 · Satyen Harish Gohil, Micaela Harrasser, et al. · Blood
A novel ROR1 chimeric antigen receptor for the treatment of haematological and solid malignancies
2016 · Gohil, SH, Della Peruta, M, et al. · UCL Discovery (University College London)
A novel bispecific T-cell engager for targeting ROR1 positive malignancies
2016 · Gohil, SH, Moscosso, SRP, et al. · UCL Discovery (University College London)
Works count: 22
Citation count: 464
H-index: 9
I10-index: 9
Year
Topic
Type